Skip to main content
TipRanks
Go Ultimate75% OFF

TherapeuticsMD (TXMD) Q4 2023 Earnings Report

2,250 Followers

TXMD Q4 2023 EPS Results

Actual EPS
-$0.13
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$8.30

TXMD Q4 2023 Revenue Results

Actual Revenue
$502.00K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+20.67%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/29/2024
Time
After Close
Conference Call
Friday, March 29, 2024
TXMD Upcoming Earnings

TherapeuticsMD's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

TXMD Earnings History

TXMD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 17, 20262026 (Q3)―-0.01――
Aug 11, 20262026 (Q2)―0.010.05-72.92% (-0.04)
May 12, 20262026 (Q1)―0.01-0.06114.29% (+0.06)
Mar 30, 20262025 (Q4)―-0.050.02-345.45% (-0.08)
Nov 12, 20252025 (Q3)―0.01-0.05126.00% (+0.06)
Aug 12, 20252025 (Q2)―0.05-0.09153.33% (+0.14)
May 13, 20252025 (Q1)―-0.06-0.0720.00% (+0.01)
Mar 27, 20252024 (Q4)―0.02-0.13116.92% (+0.15)
Nov 12, 20242024 (Q3)―-0.05-0.1361.54% (+0.08)
Aug 12, 20242024 (Q2)―-0.09-0.2462.50% (+0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed